Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
ACP has acquired Heritage Imaging, a medical devices business in New York. Heritage Imaging designs and supports imaging technology used in clinical settings, strengthening ACP’s healthcare M&A footprint in NY acquisitions. The add-on acquisition is expected to expand ACP acquisitions capabilities in medical devices acquisition and broaden service offerings for healthcare providers. ACP, a private equity buyer, is pursuing this add on acquisition as an add-on acquisition strategy, with Heritage Imaging led by CEO Dr. Steve Coppess and current management continuing post-close. Deal size was not disclosed, and the acquisition was announced with terms not publicly detailed.
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Marksans Pharma→QliniQ
Jun 1, 2026
Frazier Healthcare Partners→Altruix
May 31, 2026
Signos
May 31, 2026
Sterling Bay→Pacific Center
May 29, 2026